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measured with our sensitive score, with 56.8% of the patients having
UED after the procedure. Therefore, special attention during follow-up
regarding the upper extremity is justiﬁed, and should be implemented.
Furthermore, there are indications that certain patients might be at
higher risk and might beneﬁt from slender radial techniques or, in a
speciﬁc minor selection, a switch to transfemoral interventions. Our
UED outcome might be very sensitive, which could be excellent for
assessing the effect of hydrophilic catheter coating and other variables.
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BACKGROUND Transradial approach (TRA) for percutaneous coro-
nary intervention has been shown to decrease access site complica-
tions, bleeding and mortality compared to transfemoral approach
(TFA). However, concerns about higher access site failure rate and
door to balloon time with TRA in ST segment elevation myocardial
infarction (STEMI) remain because data from individual trials has
been conﬂicting. It has led to slow adoption of TRA in STEMI patients
compared to other indications.
METHODS The authors aimed to conduction ﬁrst comprehensive
systemic review and meta-analysis in STEMI patients evaluating
vascular access site failure rate, ﬂuoroscopy time, door to balloon time
and contrast volume used with TRA versus TFA. The PubMed,
CINAHL, clinicaltrials.gov, Embase and CENTRAL databases were
searched for randomized trials comparing TRA versus TFA in STEMI
patients. Trials not reporting data on at least one outcome of interest
were excluded. Random effect models were used to conduct this
meta-analysis with Stata software.
RESULTS Fourteen randomized trials comprising 3758 patients met
inclusion criteria. The access site failure rate was signiﬁcantly higher
TRA compared to TFA (RR 3.30, CI 2.16, 5.03). Random effect inverse
variance weighted prevalence rate meta-analysis showed that access
site failure rate is predicted to be 4% (95% CI 3-6%) with TRA versus 1%
(95%CI 0-1%)with TFA. Door to balloon time (SMD0.30minutes, 95%CI
0.23-0.37 minutes) and ﬂuoroscopy time (SMD 0.14 minutes, 95% CI
0.06-0.23 minutes) were also signiﬁcantly higher in TRA. There was no
difference in the amount of contrastmaterial usedwith TRA versus TFA
(SMD -0.05ml, 95% CI -0.14-0.04ml). Statistical heterogeneity was low
in cross-over rate and contrast volume use, moderate in ﬂuoroscopy
time but high in the door to balloon time comparison.CONCLUSIONS Cross-over rate is signiﬁcantly higher with TRA
compared to TFA in STEMI patients undergoing PCI. It is predicted to
be 3-6% with TRA versus 0-1% with TFA. Fluoroscopy and door to
balloon times are also modestly yet signiﬁcantly higher with TRA but
there is no difference in terms of contrast volume use. More research
is needed to study outcomes in STEMI patients who require cross-over
to alternate access site.
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BACKGROUND Radial approach is associated with a signiﬁcantly
reduced incidence of vascular complications and bleedings following
coronary angiography and percutaneous coronary interventions as
compared to femoral approach. Several vascular closure devices
(VCD) designed for femoral hemostasis have been proposed as an
alternative strategy in order to reduce access-related bleedings.
However, evidence about their efﬁcacy as compared to radial
approach is lacking.
METHODS In order to systematically review studies comparing radial
approach with femoral approach and achievement of hemostasis by
VCD, we conducted a search on major electronic databases entering
the following key words: “radial”, “vascular access”, “femoral”,
“coronary”, “closure devices”. Studies reporting outcomes on access-
site complications and/or major bleedings were included in the anal-
ysis. Data were extracted by two independent reviewers; odds ratio
(OR) and 95% conﬁdence interval (CI) were calculated by random-
effects model and were used as summary statistics. Review Manager
5.3 software was used for the analysis.
RESULTS Four randomized and seven non-randomized studies were
included in the meta-analysis. Outcome data about access-site com-
plications were available for 132,729 patients treated by radial
approach and 461,892 patients treated by femoral approach þ VCD,
whereas outcome data about major bleedings were available for
81,892 patients treated by radial approach and 79,884 patients treated
by femoral approach þ VCD, respectively. Both access-site complica-
tions (OR 0.29, 95% CI 0.22-0.39) and major bleedings (OR 0.43, 95%
CI 0.36-0.51) were signiﬁcantly reduced with radial approach as
compared to femoral approach þ VCD (Figure).
